Comparison of Ramosetron with Palonosetron for Prevention of Postoperative Nausea and Vomiting in Patients Receiving Opioid-Based Intravenous Patient-Controlled Analgesia after Gynecological Laparoscopy
Table 1
Patient characteristics in total and matched cohorts.
Characteristic
Total set
Matched set
Group R ()
Group P ()
STD (%)
value
Group R ()
Group P ()
STD (%)
value
Age
42.68 ± 19.96
39.64 ± 12.66
−16.34
0.056
39.95 ± 12.82
39.36 ± 14.42
−4.32
0.675
Height
159.14 ± 6.93
159.68 ± 9.21
7.21
0.418
159.23 ± 5.91
159.45 ± 8.32
3.05
0.735
Weight
57.66 ± 9.15
57.46 ± 9.74
−2.15
0.810
57.60 ± 9.03
57.51 ± 8.32
−1.04
0.923
OP time
139.21 ± 111.01
156.36 ± 165.98
13.7
0.113
136.62 ± 93.18
152.51 ± 165.53
11.83
0.263
PCA fentanyl (mcg)
1041.23 ± 145.94
1102.99 ± 195.97
39.02
<0.001
1064.63 ± 191.24
1081.55 ± 191.49
8.84
0.412
Smoking
40 (7.0)
14 (7.8)
10.81
0.712
8 (5.3)
8 (5.3)
0
1.000
PONV history
30 (5.3)
13 (7.3)
31.75
0.313
11 (7.2)
10 (6.6)
−8.33
1.000
Premedication
365 (63.9)
69 (38.5)
49.61
<0.001
69 (45.4)
63 (41.4)
−8.81
0.135
Sevoflurane
203 (35.6)
72 (40.2)
12.14
0.258
56 (36.8)
65 (42.8)
16.30
0.336
Desflurane
368 (64.4)
107 (59.8)
7.41
0.258
96 (63.2)
97 (63.8)
0.95
0.981
N2O
481 (84.2)
130 (72.6)
14.80
<0.001
122 (80.3)
118 (77.6)
−3.36
0.418
Preintubation opioid
425 (74.4)
111 (62.0)
18.18
0.001
101 (66.4)
99 (65.1)
−1.96
0.838
Remifentanil
42 (7.4)
15 (8.4)
12.66
0.652
15 (9.9)
12 (7.9)
−20.20
0.664
Acupan
289 (50.6)
54 (30.2)
50.50
<0.001
58 (38.2)
52 (34.2)
−10.47
0.504
Values are expressed as mean ± SD, absolute number (percentages), or absolute number. OP: operation, STD: standardized difference, PONV: postoperative nausea and vomiting, and PCA: patient-controlled analgesia.
